AVTR
Avantor Inc
NYSE: AVTR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$8.10
+3.18% today
Updated 2026-04-30
Market cap
$5.35B
P/E ratio
—
P/S ratio
0.82x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$7 – $16
Volume
9.5M
Avantor Inc (AVTR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $124.60M | $72.90M | $-167.50M | $200.50M | $354.00M | $929.80M | $953.60M | $843.60M | $870.00M | $840.80M | $623.80M |
| Capital expenditures | $20.90M | $29.90M | $25.20M | $37.70M | $51.60M | $61.60M | $111.10M | $133.40M | $146.40M | $148.80M | $128.80M |
| Depreciation | $-60.70M | $60.30M | $99.20M | $404.60M | $398.90M | $395.40M | $379.20M | $405.50M | $402.30M | $405.50M | $410.20M |
| Stock-based comp | $18.70M | $98.70M | $48.20M | $18.40M | $67.90M | $44.10M | $50.70M | $45.80M | $40.50M | $46.80M | $46.40M |
| Free cash flow | $103.70M | $43.00M | $-192.70M | $162.80M | $302.40M | $868.20M | $842.50M | $710.20M | $723.60M | $692.00M | $495.00M |
| Investing cash flow | $-35.40M | $-29.90M | $-6.68B | $-23.20M | $-42.10M | $-59.10M | $-4.12B | $-109.60M | $-143.70M | $438.90M | $-130.50M |
| Financing cash flow | $-87.60M | $-43.50M | $6.96B | $-170.30M | $-307.80M | $-782.90M | $3.22B | $-648.70M | $-843.70M | $-1.28B | $-409.40M |
| Dividends paid | $2.30M | $158.70M | $1.70B | $31.30M | $31.30M | $64.60M | $64.60M | $32.40M | $18.30M | $0.00 | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $87.80M | $51.10M | $85.30M | — | — | — |